MR1 presents microbial vitamin B metabolites to MAIT cells - PubMed (original) (raw)

. 2012 Nov 29;491(7426):717-23.

doi: 10.1038/nature11605. Epub 2012 Oct 10.

Onisha Patel, Alexandra J Corbett, Jérôme Le Nours, Bronwyn Meehan, Ligong Liu, Mugdha Bhati, Zhenjun Chen, Lyudmila Kostenko, Rangsima Reantragoon, Nicholas A Williamson, Anthony W Purcell, Nadine L Dudek, Malcolm J McConville, Richard A J O'Hair, George N Khairallah, Dale I Godfrey, David P Fairlie, Jamie Rossjohn, James McCluskey

Affiliations

MR1 presents microbial vitamin B metabolites to MAIT cells

Lars Kjer-Nielsen et al. Nature. 2012.

Abstract

Antigen-presenting molecules, encoded by the major histocompatibility complex (MHC) and CD1 family, bind peptide- and lipid-based antigens, respectively, for recognition by T cells. Mucosal-associated invariant T (MAIT) cells are an abundant population of innate-like T cells in humans that are activated by an antigen(s) bound to the MHC class I-like molecule MR1. Although the identity of MR1-restricted antigen(s) is unknown, it is present in numerous bacteria and yeast. Here we show that the structure and chemistry within the antigen-binding cleft of MR1 is distinct from the MHC and CD1 families. MR1 is ideally suited to bind ligands originating from vitamin metabolites. The structure of MR1 in complex with 6-formyl pterin, a folic acid (vitamin B9) metabolite, shows the pterin ring sequestered within MR1. Furthermore, we characterize related MR1-restricted vitamin derivatives, originating from the bacterial riboflavin (vitamin B2) biosynthetic pathway, which specifically and potently activate MAIT cells. Accordingly, we show that metabolites of vitamin B represent a class of antigen that are presented by MR1 for MAIT-cell immunosurveillance. As many vitamin biosynthetic pathways are unique to bacteria and yeast, our data suggest that MAIT cells use these metabolites to detect microbial infection.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. J Exp Med. 2012 Apr 9;209(4):761-74 - PubMed
    1. Nat Immunol. 2010 Aug;11(8):701-8 - PubMed
    1. Nature. 1994 Mar 17;368(6468):215-21 - PubMed
    1. Annu Rev Immunol. 2007;25:297-336 - PubMed
    1. PLoS Biol. 2010 Dec 07;8(12):e1000557 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources